Marsh & Mclennan Companies (MRSH) Cash & Equivalents (2009 - 2026)

Marsh & Mclennan Companies has reported Cash & Equivalents for 18 years, with the latest figure at $11.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 1.42% year-over-year to $11.7 billion; the trailing twelve-month figure through Mar 2026 stood at $11.7 billion (up 1.42% YoY), and the FY2025 full-year result was $11.5 billion, up 1.75% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $11.7 billion, up from $11.5 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $12.0 billion in Q3 2025, with the low at $772.0 million in Q1 2022.
• Historically, Cash & Equivalents has averaged $6.8 billion across 5 years, with a median of $10.7 billion in 2022.
• Annual changes were most pronounced in 2023 — Cash & Equivalents surged 1374.81% — and 2024, when it slumped 85.71%.
• Marsh & Mclennan Companies' Cash & Equivalents stood at $10.7 billion in 2022, then tumbled by 68.5% to $3.4 billion in 2023, then soared by 235.8% to $11.3 billion in 2024, then rose by 1.75% to $11.5 billion in 2025, then rose by 2.36% to $11.7 billion in 2026.
• The last three Cash & Equivalents figures came in at $11.7 billion (Q1 2026), $11.5 billion (Q4 2025), and $12.0 billion (Q3 2025), per Business Quant data.